Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
 Volume 64, Number 9, May 10, 2005
Right arrow Video
Right arrow Data Supplement
Right arrow Correspondence:
Submit a response
Right arrow Correspondence:
View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Klünemann, H. H.
Right arrow Articles by Paloneva, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klünemann, H. H.
Right arrow Articles by Paloneva, J.
Related Collections
Right arrow MRI
Right arrow Visual loss
Right arrow All Genetics
NEUROLOGY 2005;64:1502-1507
© 2005 American Academy of Neurology
Views & Reviews

The genetic causes of basal ganglia calcification, dementia, and bone cysts

DAP12 and TREM2

H. H. Klünemann, MD, B. H. Ridha, MRCP, L. Magy, MD, PhD, J. R. Wherrett, MD, PhD, D. M. Hemelsoet, MD, R. W. Keen, PhD, J. L. De Bleecker, MD, PhD, M. N. Rossor, MD, J. Marienhagen, MD, H. E. Klein, MD, L. Peltonen, MD, PhD and J. Paloneva, MD, PhD

From the Departments of Psychiatry and Psychotherapy (Drs. Klünemann and Klein) and Nuclear Medicine (Dr. Marienhagen), University of Regensburg School of Medicine, Germany; Dementia Research Centre (Drs. Ridha and Rossor), National Hospital for Neurology and Neurosurgery, London, UK; Neurology Service (Dr. Magy), Dupuytren University Hospital, Limoges, France; Division of Neurology (Dr. Wherrett), Toronto Western Hospital and University of Toronto, Ontario, Canada; Department of Neurology (Drs. Hemelsoet and De Bleecker), Ghent University Hospital, Belgium; The Royal National Orthopaedic Hospital (Dr. Keen), Stanmore, UK; and Department of Molecular Medicine (Drs. Peltonen and Paloneva), National Public Health Institute, Helsinki, Finland.

Address correspondence and reprint requests to Dr. Hans H. Klünemann, Certified Neurologist (American Board of Psychiatry & Neurology), Department of Psychiatry, Universitätsstr. 84, University of Regensburg School of Medicine, 93053 Regensburg, Germany; e-mail: hans.kluenemann{at}medbo.de

Background: Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL), or Nasu-Hakola disease, is a presenile dementia associated with loss of myelin, basal ganglia calcification, and bone cysts. It is caused by recessively inherited mutations in two genes encoding subunits of a cell membrane-associated receptor complex: TREM2 and DAP12. The clinical course of PLOSL has not been characterized in a series of patients with TREM2 mutations.

Methods: The authors compare neurologic and neuroradiologic follow-up data of six patients carrying TREM2 mutations with PLOSL due to defective DAP12 genes. The authors review the known mutations in these two genes.

Results: Mutations in DAP12 and TREM2 result in a uniform disease phenotype. In Finnish and Japanese patients with PLOSL, DAP12 mutations predominate, whereas TREM2 is mutated more frequently elsewhere.

Conclusions: Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy should be considered in adult patients under age 50 years with dementia and basal ganglia calcification. Radiographs of ankles and wrists, and DNA test in uncertain cases, confirm the diagnosis.

Additional material related to this article can be found on the Neurology Web site. Go to www.neurology.org and scroll down the Table of Contents for the May 10 issue to find the title link for this article.

Supported by the Academy of Finland (The Center of Excellence in Disease Genetics), the Ulla Hjelt Fond of the Foundation for Pediatric Research, the Helsinki Biomedical Graduate School, the Finnish Cultural Foundation, the Paulo Foundation, and the ReForM program of the University of Regensburg. Dr. Peltonen is the Gordon and Virginia McDonald Distinguished Chair in Human Genetics, UCLA.

Received May 13, 2004. Accepted in final form January 3, 2005.




This article has been cited by other articles:


Home page
 BrainHome page
L. Piccio, C. Buonsanti, M. Cella, I. Tassi, R. E. Schmidt, C. Fenoglio, J. Rinker II, R. T. Naismith, P. Panina-Bordignon, N. Passini, et al.
Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation
Brain, November 1, 2008; 131(11): 3081 - 3091.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
M. M. Bianchin, J. E. Lima, J. Natel, A. C. Sakamoto, H. Klunemann, B.H. Ridha, L. Magy, J.R. Wherrett, D.M. Hemelsoet, R.W. Keen, et al.
The genetic causes of basal ganglia calcification, dementia, and bone cysts: DAP12 and TREM2
Neurology, February 28, 2006; 66(4): 615 - 616.
[Full Text] [PDF]

Correspondence:

Read all Correspondence

The genetic causes of basal ganglia calcification, dementia, and bone cysts: DAP12 and TREM2
Marino Muxfeldt Bianchin, et al.
Neurology Online, 27 Jul 2005 [Full text]
Reply to Authors
Hans Klunemann, et al.
Neurology Online, 27 Jul 2005 [Full text]

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by AAN Enterprises, Inc.